Research continues, but results thus far indicate its greater efficacy for weight loss and blood sugar control
Reg Anesth Pain Med 1999;24:146-52
Clinical data from the landmark SURMOUNT-1 trial showed participants losing up to approximately 20% of their total body weight over 72 weeks, significantly more than what was achieved with older GLP-1 medications
Benefits highly effective fat burner heart support protects myocardium against damage positive effect on liver and kidneys
While a physician might theoretically prescribe it off-label, no clinical trials support this practice, and cardiovascular risks (elevated heart rate, hypertension, arrhythmias) are significant
Yes, GLP-1 medications are generally safe for Hashimoto's patients whose thyroid condition is stable and well-treated